Credit Suisse Ag Travere Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 102,710 shares of TVTX stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,710

Previous 101,944 0.75%

Holding current value

$2.09 Million

Previous $916,000 13.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.18 - $9.82 $5,499 - $7,522	766 Added 0.75%	102,710 $791,000
Q4 2023 Feb 08, 2024	BUY	$5.44 - $9.5 $219,319 - $383,002	40,316 Added 65.42%	101,944 $916,000
Q3 2023 Nov 13, 2023	SELL	$7.64 - $17.25 $191,374 - $432,095	-25,049 Reduced 28.9%	61,628 $550,000
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $505,129 - $746,469	33,015 Added 61.52%	86,677 $1.33 Million
Q1 2023 May 10, 2023	BUY	$17.82 - $22.89 $148,814 - $191,154	8,351 Added 18.43%	53,662 $1.21 Million
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $26,670 - $37,746	-1,444 Reduced 3.09%	45,311 $952,000
Q3 2022 Nov 10, 2022	BUY	$22.91 - $28.63 $104,790 - $130,953	4,574 Added 10.84%	46,755 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $62,254 - $89,219	-2,973 Reduced 6.58%	42,181 $1.02 Million
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $22,901 - $29,682	-970 Reduced 2.1%	45,154 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $150,226 - $192,381	6,172 Added 15.45%	46,124 $1.43 Million
Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $89,263 - $172,131	6,877 Added 20.79%	39,952 $970,000
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $35,528 - $66,475	-2,518 Reduced 7.07%	33,075 $482,000
Q1 2021 May 14, 2021	SELL	$23.37 - $31.77 $591,634 - $804,289	-25,316 Reduced 41.56%	35,593 $889,000
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $1.17 Million - $1.7 Million	60,909 New	60,909 $1.66 Million

Others Institutions Holding TVTX

# of Institutions

196

Shares Held

84.9M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account